L01BC05 • gemcitabine • Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Gemcitabine is a chemotherapy medication used to treat various types of cancer, including lung, pancreatic, breast, and bladder cancer. It is an antimetabolite that interferes with DNA synthesis in cancer cells.
This medication is administered intravenously, usually in cycles, according to a schedule set by the doctor. Gemcitabine helps slow the growth and spread of cancer cells.
Common side effects include nausea, vomiting, fatigue, low blood cell counts, and hair loss. In rare cases, severe reactions such as liver or lung function impairment may occur.
It is essential to follow your doctor's instructions and undergo regular tests to monitor the treatment's effects and manage potential side effects.
Substance: gemcitabine
Date of last drug list: 01-07-2013
Commercial code: W54525002
Concentration: 38mg / ml
Pharmaceutical form: perfusive solution concentrate
Packing volume: 26,3ml
Product type: generic
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.
Manufacturer: STADAPHARM GMBH - GERMANIA
Holder: STADA ARZNEIMITTEL AG - GERMANIA
Number: 10646/2018/02
Shelf life: 5 years-after packing for marketing;after the first opening-it is used immediately